Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 11/2023

17.08.2023 | Original Paper

First study demonstrating speckle tracking echocardiography has prognostic value in patients with idiopathic inflammatory myopathies

verfasst von: Luiz S. G. Machado, Ana C. D. Oliveira, Frederico J. N. Mancuso, Emilia I. Sato

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

To measure left ventricular (LV) global longitudinal strain (GLS) using speckle tracking echocardiography in idiopathic inflammatory myopathy (IIM) patients and to determine whether the LV GLS predicts outcomes in those patients. Prospective study consisted of a cross-sectional phase with 61 IIM patients and 32 individuals without IIM and longitudinal phase, in which patients were divided into two subgroups: 26 with reduced LV GLS and 35 with normal LV GLS; patients were followed for a mean of 25 months, and the occurrence of cardiovascular events and criteria for IIM activity were compared. The mean LV GLS (18.5 ± 2.9% vs. 21.6 ± 2.5%; p < 0.001) and right ventricle free wall strain (21.9 ± 6.1% vs. 27.5 ± 4.7%; p < 0.001) were lower in patients than in controls. The mean N-terminal pro B-type natriuretic peptide level was higher in patients than in controls. There were no differences regarding other cardiac involvement. Anti-Jo1 antibody was associated with general electrocardiographic abnormality and LV diastolic dysfunction. The subgroup with reduced GLS progressed with higher mean creatine phosphokinase, myositis disease activity assessment visual analogue scales, the physician’s and patient’s visual analogue scales, the health assessment questionnaire, and a higher proportion of relapses than the subgroup with normal GLS. There was no difference between the subgroups regarding cardiovascular events. The LV GLS appears to be useful for evaluating patients with IIM. Abnormal values are associated with more frequent relapses and increased disease activity during follow-up.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Dalakas MC (2020) Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol 39:289–301PubMedPubMedCentral Dalakas MC (2020) Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol 39:289–301PubMedPubMedCentral
2.
Zurück zum Zitat Zhang L, Wang GC, Ma L et al (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:686–691PubMed Zhang L, Wang GC, Ma L et al (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:686–691PubMed
3.
Zurück zum Zitat Dankó K, Ponyi A, Constantin T et al (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35–42CrossRefPubMed Dankó K, Ponyi A, Constantin T et al (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35–42CrossRefPubMed
4.
Zurück zum Zitat Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 7:360–374CrossRef Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 7:360–374CrossRef
5.
Zurück zum Zitat Kao AH, Lacomis D, Lucas M et al (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209–215CrossRefPubMed Kao AH, Lacomis D, Lucas M et al (2004) Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 50:209–215CrossRefPubMed
6.
Zurück zum Zitat Ungprasert P, Suksaranjit P, Spanuchart I et al (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 44:63–67CrossRefPubMed Ungprasert P, Suksaranjit P, Spanuchart I et al (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 44:63–67CrossRefPubMed
7.
Zurück zum Zitat Hughes M, Lilleker JB, Herrick AL et al (2015) Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity. Ann Rheum Dis 74:795–798CrossRefPubMed Hughes M, Lilleker JB, Herrick AL et al (2015) Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity. Ann Rheum Dis 74:795–798CrossRefPubMed
8.
Zurück zum Zitat Erlacher P, Lercher A, Falkensammer J et al (2001) Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306:27–33CrossRefPubMed Erlacher P, Lercher A, Falkensammer J et al (2001) Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306:27–33CrossRefPubMed
9.
Zurück zum Zitat Diederichsen LP, Simonsen JA, Diederichsen AC et al (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res (Hoboken) 68:1012–1020CrossRefPubMed Diederichsen LP, Simonsen JA, Diederichsen AC et al (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res (Hoboken) 68:1012–1020CrossRefPubMed
10.
Zurück zum Zitat Lu Z, Wei Q, Ning Z et al (2013) Left ventricular diastolic dysfunction—early cardiac impairment in patients with polymyositis/dermatomyositis: a tissue Doppler imaging study. J Rheumatol 40:1572–1577CrossRefPubMed Lu Z, Wei Q, Ning Z et al (2013) Left ventricular diastolic dysfunction—early cardiac impairment in patients with polymyositis/dermatomyositis: a tissue Doppler imaging study. J Rheumatol 40:1572–1577CrossRefPubMed
11.
Zurück zum Zitat Zhong Y, Bai W, Xie Q et al (2018) Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study. Int J Cardiovasc Imaging 34:683–693PubMed Zhong Y, Bai W, Xie Q et al (2018) Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study. Int J Cardiovasc Imaging 34:683–693PubMed
12.
Zurück zum Zitat Guerra F, Gelardi C, Capucci A et al (2017) Subclinical cardiac dysfunction in polymyositis and dermatomyositis: a speckle-tracking case-control study. J Rheumatol 44:815–821CrossRefPubMed Guerra F, Gelardi C, Capucci A et al (2017) Subclinical cardiac dysfunction in polymyositis and dermatomyositis: a speckle-tracking case-control study. J Rheumatol 44:815–821CrossRefPubMed
13.
Zurück zum Zitat Smiseth OA, Torp H, Opdahl A et al (2016) Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 37:1196–1207CrossRefPubMed Smiseth OA, Torp H, Opdahl A et al (2016) Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 37:1196–1207CrossRefPubMed
14.
Zurück zum Zitat Reisner SA, Lysyansky P, Agmon Y et al (2004) Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 17(6):630–633CrossRefPubMed Reisner SA, Lysyansky P, Agmon Y et al (2004) Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 17(6):630–633CrossRefPubMed
15.
Zurück zum Zitat Carlsson M, Ugander M, Heiberg E et al (2007) The quantitative relationship between longitudinal and radial function in left, right, and total heart pumping in humans. Am J Physiol Heart Circ Physiol 293(1):H636–H644CrossRefPubMed Carlsson M, Ugander M, Heiberg E et al (2007) The quantitative relationship between longitudinal and radial function in left, right, and total heart pumping in humans. Am J Physiol Heart Circ Physiol 293(1):H636–H644CrossRefPubMed
16.
Zurück zum Zitat Cioffi G, Viapiana O, Ognibeni F et al (2017) Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis. J Am Soc Echocardiogr 30:602–611CrossRefPubMed Cioffi G, Viapiana O, Ognibeni F et al (2017) Prognostic role of subclinical left ventricular systolic dysfunction evaluated by speckle-tracking echocardiography in rheumatoid arthritis. J Am Soc Echocardiogr 30:602–611CrossRefPubMed
17.
Zurück zum Zitat Lo Gullo A, Rodriguez-Carrio J, Aragona CO et al (2018) Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: association with vitamin D and inflammation. Atherosclerosis 271:214–222CrossRefPubMed Lo Gullo A, Rodriguez-Carrio J, Aragona CO et al (2018) Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: association with vitamin D and inflammation. Atherosclerosis 271:214–222CrossRefPubMed
18.
Zurück zum Zitat Huang BT, Yao HM, Huang H (2014) Left ventricular remodeling and dysfunction in systemic lupus erythematosus: a three-dimensional speckle tracking study. Echocardiography 31:1085–1094CrossRefPubMed Huang BT, Yao HM, Huang H (2014) Left ventricular remodeling and dysfunction in systemic lupus erythematosus: a three-dimensional speckle tracking study. Echocardiography 31:1085–1094CrossRefPubMed
19.
Zurück zum Zitat Lundberg IE, Tjarnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69(12):2271–2282CrossRefPubMedPubMedCentral Lundberg IE, Tjarnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69(12):2271–2282CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Isenberg DA, Allen E, Farewell V et al (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult-onset disease. Rheumatology (Oxford) 43(1):49–54CrossRefPubMed Isenberg DA, Allen E, Farewell V et al (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult-onset disease. Rheumatology (Oxford) 43(1):49–54CrossRefPubMed
21.
Zurück zum Zitat Rider LG (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):S118–S157PubMed Rider LG (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 63(Suppl 11):S118–S157PubMed
22.
Zurück zum Zitat Rider LG, Giannini EH, Brunner HI et al (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50:2281–2290CrossRefPubMed Rider LG, Giannini EH, Brunner HI et al (2004) International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 50:2281–2290CrossRefPubMed
23.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39CrossRefPubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39CrossRefPubMed
24.
Zurück zum Zitat Nagueh SF, Smiseth OA, Appleton CP (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314CrossRefPubMed Nagueh SF, Smiseth OA, Appleton CP (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29:277–314CrossRefPubMed
25.
Zurück zum Zitat Surawicz B, Knilans TK (2008) Chou’s electrocardiography in clinical practice, 6th edn. Elsevier, Philadelphia Surawicz B, Knilans TK (2008) Chou’s electrocardiography in clinical practice, 6th edn. Elsevier, Philadelphia
26.
Zurück zum Zitat Péter A, Balogh A, Szilagyi S et al (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281CrossRefPubMed Péter A, Balogh A, Szilagyi S et al (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281CrossRefPubMed
27.
Zurück zum Zitat Barsotti S, Neri R, Iacopetti V et al (2013) AB0839 Evaluation of serum levels of N-terminal prob-type natriuretic peptide (NT-PROBNP) in patients with polymyositis and dermatomyositis (PM/DM): preliminary data. Ann Rheum Dis 71:686CrossRef Barsotti S, Neri R, Iacopetti V et al (2013) AB0839 Evaluation of serum levels of N-terminal prob-type natriuretic peptide (NT-PROBNP) in patients with polymyositis and dermatomyositis (PM/DM): preliminary data. Ann Rheum Dis 71:686CrossRef
28.
Zurück zum Zitat Hervier B, Meyer A, Dieval C et al (2013) Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 42:1271–1282CrossRefPubMed Hervier B, Meyer A, Dieval C et al (2013) Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J 42:1271–1282CrossRefPubMed
29.
Zurück zum Zitat Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280(1):8–23CrossRefPubMed Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280(1):8–23CrossRefPubMed
31.
Zurück zum Zitat Defendenti C, Atzeni F, Spina MF et al (2011) Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Ver 10:150–154CrossRef Defendenti C, Atzeni F, Spina MF et al (2011) Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Ver 10:150–154CrossRef
32.
Zurück zum Zitat Hensel OK, Jenke A, Leischik R (2014) Speckle-tracking and tissue-Doppler stress echocardiography in arterial hypertension: a sensitive tool for detection of subclinical LV impairment. Biomed Res Int 2014:472562CrossRefPubMedPubMedCentral Hensel OK, Jenke A, Leischik R (2014) Speckle-tracking and tissue-Doppler stress echocardiography in arterial hypertension: a sensitive tool for detection of subclinical LV impairment. Biomed Res Int 2014:472562CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zhang L, Chen X (2017) Investigation of the predictive value of speckle tracking imaging for the assessment of cardiac function and clinical prognosis in patients with hypercholesterolemia. Exp Ther Med 13(6):2951–2959CrossRefPubMedPubMedCentral Zhang L, Chen X (2017) Investigation of the predictive value of speckle tracking imaging for the assessment of cardiac function and clinical prognosis in patients with hypercholesterolemia. Exp Ther Med 13(6):2951–2959CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Diniz MFR, Kozu KT, Elias AM et al (2021) Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain. Clin Rheumatol 40(4):1497–1505CrossRefPubMed Diniz MFR, Kozu KT, Elias AM et al (2021) Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain. Clin Rheumatol 40(4):1497–1505CrossRefPubMed
35.
Zurück zum Zitat Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100:1673–1680CrossRefPubMed Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 100:1673–1680CrossRefPubMed
Metadaten
Titel
First study demonstrating speckle tracking echocardiography has prognostic value in patients with idiopathic inflammatory myopathies
verfasst von
Luiz S. G. Machado
Ana C. D. Oliveira
Frederico J. N. Mancuso
Emilia I. Sato
Publikationsdatum
17.08.2023
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 11/2023
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-02925-8

Weitere Artikel der Ausgabe 11/2023

The International Journal of Cardiovascular Imaging 11/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.